HilleVax, Inc. financial data

Symbol
HLVX on Nasdaq
Location
321 Harrison Ave, Suite 500, Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.64K % +71.2%
Debt-to-equity 20.3 % -30.5%
Return On Equity -44.6 % +28.1%
Return On Assets -37.1 % +22.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.1M shares +0.72%
Common Stock, Shares, Outstanding 50.1M shares +1.7%
Entity Public Float 345M USD +33.6%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 50.1M shares +1.9%
Weighted Average Number of Shares Outstanding, Diluted 50.1M shares +1.9%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 23.4M USD -22.5%
Operating Income (Loss) -77.1M USD +53.8%
Nonoperating Income (Expense) 6.02M USD -43.7%
Net Income (Loss) Attributable to Parent -71.1M USD +54.5%
Earnings Per Share, Basic -1 USD/shares +57.8%
Earnings Per Share, Diluted -1 USD/shares +57.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.7M USD -45.9%
Marketable Securities, Current 101M USD -26.2%
Assets, Current 162M USD -35.8%
Property, Plant and Equipment, Net 4.03M USD -61.2%
Operating Lease, Right-of-Use Asset 6.99M USD -43.6%
Other Assets, Noncurrent 26K USD +13%
Assets 175M USD -36.8%
Accounts Payable, Current 113K USD -97.1%
Employee-related Liabilities, Current 579K USD +22.2%
Accrued Liabilities, Current 2.4M USD -85%
Liabilities, Current 6.15M USD -87.5%
Operating Lease, Liability, Noncurrent 19.9M USD -9.06%
Other Liabilities, Noncurrent 1.04M USD +10.2%
Liabilities 27.1M USD -62.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.24M USD -32.2%
Retained Earnings (Accumulated Deficit) -547M USD -14.9%
Stockholders' Equity Attributable to Parent 148M USD -27.9%
Liabilities and Equity 175M USD -36.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.7M USD +61.5%
Net Cash Provided by (Used in) Financing Activities 15.1M USD +18728%
Net Cash Provided by (Used in) Investing Activities -94.3M USD -63.5%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 50.1M shares +0.72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -107M USD -41.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 382K USD +99%
Deferred Tax Assets, Valuation Allowance 81.3M USD +49.3%
Deferred Tax Assets, Gross 82.9M USD +41.9%
Operating Lease, Liability 23.5M USD -7.36%
Depreciation 1.47M USD -10%
Payments to Acquire Property, Plant, and Equipment 153K USD -94.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -71.4M USD +54.5%
Lessee, Operating Lease, Liability, to be Paid 30.6M USD -10.5%
Property, Plant and Equipment, Gross 6.59M USD -45.9%
Operating Lease, Liability, Current 3.63M USD +3.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.79M USD +2.82%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.85M USD +3.18%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.06M USD -19.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.86M USD +2.11%
Deferred Tax Assets, Operating Loss Carryforwards 24.7M USD +139%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 976K USD +1.77%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.98M USD +3.06%
Operating Lease, Payments 923K USD +3.01%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.57M USD -60.2%
Share-based Payment Arrangement, Expense 14.3M USD -24.6%
Interest Expense 2.91M USD +106%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%